Dr. Yu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000Fax+1 212-794-5847- Is this information wrong?
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2010 - 2013
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
- Harvard Medical SchoolClass of 2007
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2010 - 2025
- NJ State Medical License 2020 - 2025
- CT State Medical License 2023 - 2024
- PA State Medical License 2007 - 2010
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification Start of enrollment: 2014 Jun 24
- A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients Start of enrollment: 2019 Mar 22
Publications & Presentations
PubMed
- 1 citationsAssociation of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast Cancer.Anthony F Yu, Zachary R Moore, Chaya S Moskowitz, Jennifer E Liu, Chau T Dang, Lakshmi Ramanathan, Kevin C Oeffinger, Richard M Steingart, Adam M Schmitt> ;JAMA Cardiology. 2023 Jul 1
- 1 citationsRationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy.Anthony F Yu, Chau T Dang, Justine Jorgensen, Chaya S Moskowitz, Patricia DeFusco, Eric Oligino, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart> ;Cardio-Oncology. 2023 Mar 9
- 3 citationsInnate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies.Achraf Shamseddine, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody Di Bona, Jun Li, Chau T Dang, Lakshmi V Ramanathan, Kevin C Oeffinger, Jenn...> ;The Journal of Experimental Medicine. 2023 Mar 6
- Join now to see all
Press Mentions
- Breast Cancer Linked to Higher Odds for Dangerous a-fibNovember 16th, 2021
- Bad News on Anti-HER2 Heart EffectsJanuary 15th, 2020
Professional Memberships
- Member
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: